Target intelligence / Profile preview

Poly(ADP-ribose) polymerase family member 12 (PARP12)

Target
PARP12
Molecular classification
Enzyme, Mono-ADP-ribosyltransferase, Zinc finger protein, Poly(ADP-ribose) polymerase (PARP) family
01

Overview

Poly(ADP-ribose) polymerase family member 12 (PARP12) is an enzyme belonging to the PARP superfamily, characterized as a mono-ADP-ribosyltransferase. It contains CCCH-type zinc finger domains and WWE domains, enabling interactions with RNA and poly-ADP-ribose (PAR), and is involved in nuclear, cytoplasmic, and stress granule processes. PARP12 performs mono-ADP-ribosylation of target proteins, including RIPK1 and RIPK3, regulating cell death pathways such as necroptosis and apoptosis, particularly in response to TNFα and interferon signaling[4][5]. It also plays a role in antiviral defense, stress granule assembly, and the regulation of protein transport between the Golgi apparatus and plasma membrane[2][1]. In cancer (e.g., hepatocellular carcinoma), it impacts cancer cell migration and invasion by controlling the stability of proteins such as FHL2[1]. PARP12 is also highly expressed in brown adipose tissue, where it is implicated in mitochondrial function and thermogenesis[3]. There are no well-characterized drugs currently targeting PARP12, and it is considered a non-redundant modulator within the broader family of ADP-ribosyltransferases.

Other names
Protein mono-ADP-ribosyltransferase PARP12ZC3HDC1ARTD12PARP-12FLJ22693ZC3H1MST109MSTP109Zinc finger CCCH domain-containing protein 1ADP-ribosyltransferase diphtheria toxin-like 12
02

Mechanism of action

Mono-ADP-ribosylation of proteins affecting cell death pathways (e.g., MARylation of RIPK1, RIPK3); Modulation of protein stability and trafficking pathways; Regulation of stress granule dynamics under stress conditions

03

Biological functions

Protein ADP-ribosylationRegulation of cell death (apoptosis, necroptosis)Antiviral responseStress response/granule assemblyProtein translation regulationRegulation of intracellular traffickingRegulation of mitochondrial function
04

Disease associations

Cancer (notably hepatocellular carcinoma)Infection (notably antiviral functions)Metabolic disease (mitochondrial dysfunction in adipocytes)Possibly neurodevelopmental disorders
05

Safety considerations

Potential effects on cell death pathways (apoptosis/necroptosis)Possible disruption of protein translation or cellular stress responses

Beyond the preview

Go deeper on Poly(ADP-ribose) polymerase family member 12 (PARP12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly(ADP-ribose) polymerase family member 12 (PARP12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call